240-week entecavir maleate treatment in Chinese chronic hepatitis B predominantly genotype B or C.

J Viral Hepat · 2022 · PMC9545224 · PMID 35737855

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

3.3 Serologic endpoints With the prolongation of treatment time, the serum HBeAg loss rate and HBeAg seroconversion rate in both groups showed an increasing trend.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.